FDA Issues Guidance on Human Factors Information in Marketing Submissions

FDA Issues Guidance on Human Factors Information in Marketing Submissions

The FDA's Risk-Based Framework

The FDA has issued guidance titled "Content of Human Factors Information in Medical Device Marketing Submissions," which provides a risk-based framework to guide manufacturers and FDA staff on the human factors information that should be included in marketing submissions.

The guidance document establishes expectations for how manufacturers should present human factors data when seeking FDA clearance or approval. By adopting a risk-based approach, the framework allows manufacturers to tailor their submissions to the complexity and risk profile of their devices, rather than applying a one-size-fits-all standard. This approach recognizes that the depth and scope of human factors information needed varies depending on device type, intended use, and potential for user error.

For FDA staff responsible for reviewing submissions, the guidance serves as a reference tool for assessing whether manufacturers have adequately characterized the human factors aspects of device design, labeling, and training. The framework helps ensure consistency in how the agency evaluates these submissions across different device centers and programs.

IntelligenceRegulatory Impact▾

FDA decisions frame this story. Regulatory relevance is medium for this topic. Track designations, submission types, and label or guidance shifts that could move timelines.

What the Guidance Covers

The guidance includes recommendations for the content of human factors engineering and usability engineering (HFE/UE) information included in submissions. These recommendations specify what types of human factors and usability engineering data manufacturers should consider including when they apply for FDA review.

Human factors engineering encompasses the study of how users interact with devices, including factors such as device design, user interface, labeling, and training materials. Usability engineering builds on this foundation by testing whether the device can be used safely and effectively by its intended users under actual or simulated conditions of use. The guidance clarifies what information in these areas the FDA expects to see in marketing submissions.

The risk-based framework means that manufacturers of higher-risk devices or those with more complex user interfaces may need to provide more comprehensive human factors data than manufacturers of simpler, lower-risk devices. This proportional approach allows the FDA to focus its review resources on the submissions where human factors considerations are most critical to safe and effective device use.

IntelligenceMarket Signals▾

Commercial pull is medium and investment relevance low for this topic. Expect implications for pricing, access, and launch sequencing.

Applying Human Factors and Usability Engineering to Medical Devices

Medical device manufacturers have long recognized that how users interact with a device directly affects its safety and effectiveness. The FDA guidance on applying human factors and usability engineering to medical devices formalizes expectations around this discipline. By providing clear recommendations on what information should be included in submissions, the guidance helps manufacturers understand what the agency considers essential for demonstrating that a device can be used safely by its intended users.

The emphasis on human factors and usability engineering reflects broader FDA efforts to prevent use errors and adverse events that stem from poor device design or inadequate labeling and training. When manufacturers systematically apply human factors principles during device development and document their work, they create a foundation for safer devices and more efficient FDA reviews.

IntelligenceStrategic Takeaways▾

The FDA released guidance on human factors information in medical device marketing submissions. The guidance provides a risk-based framework for manufacturers and FDA staff. The document recommends the content of human factors engineering and usability engineering (HFE/UE) information in submissions.

Key Takeaways

• The FDA released guidance on human factors information in medical device marketing submissions.
• The guidance provides a risk-based framework for manufacturers and FDA staff.
• The document recommends the content of human factors engineering and usability engineering (HFE/UE) information in submissions.
• The framework allows manufacturers to tailor submissions based on device risk and complexity.
• Applying human factors and usability engineering to medical devices is central to demonstrating safe and effective use.

Frequently Asked Questions